The role of oxidative stress and antioxidants in diabetic wound healing
L Deng, C Du, P Song, T Chen, S Rui… - Oxidative medicine …, 2021 - Wiley Online Library
Foot ulcers are one of the most common and severe complication of diabetes mellitus with
significant resultant morbidity and mortality. Multiple factors impair wound healing include …
significant resultant morbidity and mortality. Multiple factors impair wound healing include …
The role of Nrf2 in cardiovascular function and disease
S Satta, AM Mahmoud, FL Wilkinson… - Oxidative medicine …, 2017 - Wiley Online Library
Free radicals, reactive oxygen/nitrogen species (ROS/RNS), hydrogen sulphide, and
hydrogen peroxide play an important role in both intracellular and intercellular signaling; …
hydrogen peroxide play an important role in both intracellular and intercellular signaling; …
Sitagliptin activates the p62–Keap1–Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung …
L Kong, J Deng, X Zhou, B Cai, B Zhang, X Chen… - Cell death & …, 2021 - nature.com
Acute lung injury (ALI) is a complication of severe acute pancreatitis (SAP). Sitagliptin (SIT)
is a DPP4 inhibitor that exerts anti-inflammatory and antioxidant effects; however, its …
is a DPP4 inhibitor that exerts anti-inflammatory and antioxidant effects; however, its …
Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases
Free radicals act as secondary messengers, modulating a number of important biological
processes, including gene expression, ion mobilization in transport systems, protein …
processes, including gene expression, ion mobilization in transport systems, protein …
[HTML][HTML] Vildagliptin attenuates Huntington's disease through activation of GLP-1 receptor/PI3K/Akt/BDNF pathway in 3-nitropropionic acid rat model
Vildagliptin (Vilda), a dipeptidyl peptidase-4 (DPP-4) inhibitor, has been highlighted as a
promising therapeutic agent for neurodegenerative diseases as Alzheimer's and Parkinson's …
promising therapeutic agent for neurodegenerative diseases as Alzheimer's and Parkinson's …
Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity
HM Abo-Haded, MA Elkablawy, Z Al-Johani… - PloS one, 2017 - journals.plos.org
Sitagliptin is selective dipeptidyl peptidase-4 inhibitor (DPP4-I), used clinically as a new oral
anti-diabetic agent. This study explored the underlying mechanisms of the hepatoprotective …
anti-diabetic agent. This study explored the underlying mechanisms of the hepatoprotective …
Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway
Z Chen, J Yu, M Fu, R Dong, Y Yang, J Luo… - Biochemical …, 2020 - Elsevier
Abstract Dipeptidyl peptidase-4 (DPP4) is elevated in numerous cardiovascular pathological
processes and DPP4 inhibition is associated with reduced inflammation and oxidative …
processes and DPP4 inhibition is associated with reduced inflammation and oxidative …
[HTML][HTML] Reactive oxygen comes of age: mechanism-based therapy of diabetic end-organ damage
MH Elbatreek, MP Pachado, A Cuadrado… - Trends in Endocrinology …, 2019 - cell.com
Reactive oxygen species (ROS) have been mainly viewed as unwanted by-products of
cellular metabolism, oxidative stress, a sign of a cellular redox imbalance, and potential …
cellular metabolism, oxidative stress, a sign of a cellular redox imbalance, and potential …
Emerging Screening Approaches in the development of Nrf2–Keap1 protein–protein interaction inhibitors
Due to role of the Keap1–Nrf2 protein–protein interaction (PPI) in protecting cells from
oxidative stress, the development of small molecule inhibitors that inhibit this interaction has …
oxidative stress, the development of small molecule inhibitors that inhibit this interaction has …
Incretins-based therapies and their cardiovascular effects: new game-changers for the management of patients with diabetes and cardiovascular disease
F Bernardini, A Nusca, F Coletti, Y La Porta, M Piscione… - Pharmaceutics, 2023 - mdpi.com
Atherosclerosis is the leading cause of death worldwide, especially in patients with type 2
diabetes mellitus (T2D). GLP-1 receptor agonists and DPP-4 inhibitors were demonstrated …
diabetes mellitus (T2D). GLP-1 receptor agonists and DPP-4 inhibitors were demonstrated …